Literature DB >> 3930607

H-2-restricted cytolysis of L cells doubly transformed with a cloned H-2Kb gene and cloned retroviral DNA.

J P Abastado, F Plata, D Morello, F Daniel-Vedele, P Kourilsky.   

Abstract

We report the construction of target cells by the double transformation of mouse L cells with a cloned H-2Kb gene and molecular clones of Akv or Gross murine leukemia virus (MuLV) or the cloned gag gene of Akv MuLV. Cytolytic T lymphocytes (CTL) generated in BALB.B mice specific for Gross MuLV (closely related to Akv MuLV) kill these doubly transformed cells. This is a direct indication that a CTL subpopulation recognizes H-2Kb antigen in association with a viral antigen encoded by the gag gene of Gross MuLV.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3930607

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Mechanism of escape of endogenous murine leukemia virus emv-14 from recognition by anti-AKR/Gross virus cytolytic T lymphocytes.

Authors:  H D White; M D Robbins; W R Green
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

2.  Alternative splicing in the mouse H-2Kd gene is not necessary for the classical Kd antigen function.

Authors:  M Cochet; W M Kast; A M Kummer; C Transy; C J Melief; P Kourilsky
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Retroviral properties inherent to viral erythrocytic infection in sea bass.

Authors:  R M Pintó; E Ribes; J Jofre; A Bosch
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities.

Authors:  C A Holt; K Osorio; F Lilly
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

5.  Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytes.

Authors:  Y Kaneko; H F Oettgen; Y Obata; E Nakayama
Journal:  Jpn J Cancer Res       Date:  1989-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.